Head and Neck Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Head and Neck Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-06-27Clinical Trial Update: Study of SCB01A in Patient With Head and Neck Cancer [Phase 2]
Phase 2 trial update for SCB01A in head and neck squamous cell carcinoma has been terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2023-06-12Clinical Trial Update: Durvalumab, Tremelimumab and Hypofractionated Radiation Therapy in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma [Phase 1, Phase 2]
Clinical trial investigating durvalumab, tremelimumab, and hypofractionated radiation therapy in patients with recurrent or metastatic head …
-
CLINICAL_TRIALS trial_result · 2023-06-08Clinical Trial Update: Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412) [Phase 3]
Phase 3 trial evaluating pembrolizumab with chemoradiation versus placebo in locally advanced head and neck squamous cell carcinoma complete…
-
CLINICAL_TRIALS trial_result · 2023-06-01Clinical Trial Update: Paclitaxel, Carboplatin And Low Dose Radiation As Induction Therapy In Locally Advanced Head And Neck Cancer [Phase 2]
Phase 2 trial evaluating paclitaxel, carboplatin, and low-dose radiation as induction therapy for locally advanced head and neck squamous ce…
-
CLINICAL_TRIALS trial_result · 2023-05-18Clinical Trial Update: Mitomycin C in Patients With Incurable p16 Positive Oropharyngeal and p16 Negative Head and Neck Squamous Cell Carcinoma (HNSCC) Resistant to Standard Therapies [Phase 2]
Phase 2 trial of mitomycin C in patients with incurable head and neck squamous cell carcinoma (p16-positive and p16-negative) resistant to s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-05-17Clinical Trial Update: Neoadjuvant Radiotherapy Combined With Toripalimab for Locally Advanced Head and Neck Squamous Cell Carcinoma [Phase 2]
Phase 2 trial evaluating neoadjuvant radiotherapy combined with toripalimab for locally advanced head and neck squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2023-05-12Clinical Trial Update: Study of Monalizumab and Cetuximab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating monalizumab in combination with cetuximab for recurrent or metastatic squamous cell carcinoma of the h…
-
CLINICAL_TRIALS trial_result · 2023-05-11Clinical Trial Update: Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma [Phase 2]
Phase 2 trial update reports results for pembrolizumab (MK-3475) in surgically resectable head and neck squamous cell carcinoma. The study s…
-
CLINICAL_TRIALS trial_result · 2023-05-09Clinical Trial Update: Optimizing Antitumor Immunity Using Plasmid Electroporation, Pembrolizumab, and Epacadostat [Phase 2]
Phase 2 trial investigating plasmid electroporation with pembrolizumab and epacadostat in metastatic/recurrent unresectable head and neck sq…
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Phase II Trial of Adjuvant Cisplatin and Radiation With Pembrolizumab in Resected Head and Neck Squamous Cell Carcinoma [Phase 2]
This entry reports results posting for a Phase II trial evaluating adjuvant cisplatin and radiation with pembrolizumab in patients with rese…
-
CLINICAL_TRIALS trial_result · 2023-04-07Clinical Trial Update: A Study of Duvelisib in Combination With Pembrolizumab in Head and Neck Cancer [Phase 1, Phase 2]
A phase 1/2 study of duvelisib in combination with pembrolizumab in head and neck squamous cell carcinoma was terminated, with results poste…
-
CLINICAL_TRIALS trial_result · 2023-04-03Clinical Trial Update: A Study of CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell Carcinoma [Phase 2]
Phase 2 trial of CDX-3379 with cetuximab in advanced head and neck squamous cell carcinoma was terminated with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-03-21Clinical Trial Update: Window of Opportunity Trial of Durvalumab (MEDI4736) or Durvalumab/Tremelimumab as Neoadjuvant Chemotherapy to Identify Immune Dynamics in Surgically Resectable Head and Neck Cancer Patients. [Phase 2]
Phase 2 window-of-opportunity trial evaluating Durvalumab alone or Durvalumab plus Tremelimumab as neoadjuvant therapy to study immune dynam…
-
CLINICAL_TRIALS trial_result · 2023-03-09Clinical Trial Update: Los Tres Paso: Neoadjuvant Palbociclib Monotherapy, Concurrent Chemoradiation Therapy, Adjuvant Palbociclib Monotherapy in Patients With p16INK4a Negative, HPV-Unrelated Head and Neck Squamous Cell Carcinoma [Phase 2]
Phase 2 trial evaluating palbociclib as neoadjuvant and adjuvant monotherapy, and with concurrent chemoradiation, in p16INK4a-negative, HPV-…
-
CLINICAL_TRIALS trial_result · 2023-03-08Clinical Trial Update: REVEAL Study of NKTR-262 in Combination With NKTR-214 and Nivolumab in Patients With Locally Advanced / Metastatic Solid Tumor Malignancies [Phase 1, Phase 2]
Phase 1/2 trial REVEAL exploring NKTR-262 with NKTR-214 and nivolumab in various locally advanced/metastatic solid tumors was terminated; re…
-
CLINICAL_TRIALS trial_result · 2023-02-28Clinical Trial Update: Study of Nimotuzumab and Cisplatin/Radiotherapy for Locally Advanced Head and Neck Squamous Cell Cancer [Phase 2]
Phase 2 clinical trial update evaluating nimotuzumab with cisplatin/radiotherapy in locally advanced head and neck squamous cell cancer has …
-
CLINICAL_TRIALS trial_result · 2023-02-17Clinical Trial Update: Efficacy and Safety of Immunotherapy Combined With Neoadjuvant Chemotherapy in Patients With Locally Advanced HPV (-) Head and Neck Squamous Cell Carcinoma: a Phase II Clinical Trial [Phase 2]
Phase II trial evaluating the combination of immunotherapy with neoadjuvant chemotherapy for locally advanced HPV-negative head and neck squ…
-
CLINICAL_TRIALS trial_result · 2023-02-10Clinical Trial Update: Cetuximab Plus Dalpicilib in Patients With HPV Negative, PD-1 Resistant R/M HNSCC [Phase 2]
Phase 2 clinical trial evaluating cetuximab plus dalpicilib in HPV-negative, PD-1 resistant recurrent/metastatic head and neck squamous cell…
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma [Phase 2]
Phase 2 trial evaluating preoperative and adjuvant therapy with carboplatin, nab-paclitaxel, and durvalumab for head and neck squamous cell …
-
CLINICAL_TRIALS trial_result · 2023-01-11Clinical Trial Update: Phase 2 Study of OBP-301 (Telomelysin™) in Combination With Pembrolizumab and SBRT in Patients With HNSCC With Inoperable, Recurrent or Progressive Disease [Phase 2]
Phase 2 trial of OBP-301 (Telomelysin) in combination with pembrolizumab and SBRT in head and neck squamous cell carcinoma with inoperable, …
-
CLINICAL_TRIALS trial_result · 2022-12-20Clinical Trial Update: Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma [Phase 1, Phase 2]
A Phase 1/2 study evaluating the combination of cetuximab and nivolumab in recurrent or metastatic head and neck squamous cell carcinoma has…
-
CLINICAL_TRIALS trial_result · 2022-12-19Clinical Trial Update: A Study of Toripalimab Injection (JS001) + Cetuximab in Treatment of Advanced Head and Neck Squamous Cell Cancer [Phase 1, Phase 2]
Ongoing early-phase study evaluating toripalimab with cetuximab for advanced head and neck squamous cell cancer.
-
CLINICAL_TRIALS trial_result · 2022-12-02Clinical Trial Update: A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers [Phase 1, Phase 2]
Phase 1/2 trial evaluating tremelimumab and IV durvalumab with Poly-ICLC in biopsy-accessible cancers; completed with results posted in 2022…
-
CLINICAL_TRIALS trial_result · 2022-11-10Clinical Trial Update: Panitumumab-IRDye800 Compared to Sentinel Node Biopsy and (Selective) Neck Dissection in Identifying Metastatic Lymph Nodes in Patients With Head&Neck Cancer [Phase 2]
Phase 2 trial comparing panitumumab-IRDye800 imaging against sentinel node biopsy and selective neck dissection for identifying metastatic l…
-
CLINICAL_TRIALS trial_result · 2022-11-02Clinical Trial Update: A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A clinical trial update for T3011 administered intratumorally in advanced solid tumors, including phase 1 and phase 2 cohorts.